Body Fat Depletion: the Yin Paradigm for Treating Type 2 Diabetes.
Journal Information
Full Title: Curr Atheroscler Rep
Abbreviation: Curr Atheroscler Rep
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Competing InterestsConflicts of Interest: Professor Wilding reports grants and personal fees from AstraZeneca; personal fees and consultancy fees paid to his institution from Boehringer Ingelheim; grants; personal fees and consultancy paid to his institution from Novo Nordisk; consultancy fees paid to his institution from Altimmune, Eli Lilly, Menarini, Napp, Pfizer, Rhythm Pharmaceuticals, Saniona, Tern, Shionogi, and Ysopia, outside the submitted work. Dr. Zhu reports no conflict of interest. Human and Animal RightsAll reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines). Competing Interests Conflicts of Interest: Professor Wilding reports grants and personal fees from AstraZeneca; personal fees and consultancy fees paid to his institution from Boehringer Ingelheim; grants; personal fees and consultancy paid to his institution from Novo Nordisk; consultancy fees paid to his institution from Altimmune, Eli Lilly, Menarini, Napp, Pfizer, Rhythm Pharmaceuticals, Saniona, Tern, Shionogi, and Ysopia, outside the submitted work. Dr. Zhu reports no conflict of interest."
"Funding Dr. Zhu reports grants from The China Scholarship Council (grant number: 202006920018), The Second Affiliated Hospital of Soochow University (grant number: SDFEYBS1815), and The Jiangsu Innovation & Career Fund for PhD 2019, for supporting the conduct of the study."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025